The epidemiology of lung cancer following radiation exposure

Lydia B. Zablotska, David B. Richardson, Ashley Golden, Elisa Pasqual, Brian Smith, Estelle Rage, Paul A. Demers, Minh Do, Nora Fenske, Veronika Deffner, Michaela Kreuzer, Jonathan Samet, Stephen Bertke, Kaitlin Kelly-Reif, Mary K. Schubauer-Berigan, Ladislav Tomasek, Charles Wiggins, Dominque Laurier, Iulian Apostoaei, Brian A. ThomasSteven L. Simon, F. Owen Hoffman, John D. Boice, Lawrence T. Dauer, Sara C. Howard, Sarah S. Cohen, Michael T. Mumma, Elizabeth D. Ellis, Keith F. Eckerman, Rich W. Leggett, David J. Pawel

Research output: Contribution to journalArticlepeer-review

3 Scopus citations
Original languageEnglish
Pages (from-to)569-580
Number of pages12
JournalInternational Journal of Radiation Biology
Volume99
Issue number3
DOIs
StatePublished - 2023

Funding

The work relating to PUMA (Richardson et al.) was supported by the Centers for Disease Control and Prevention (CDC, R03 OH010946). The construction of the French cohort was partially supported by the Institute for Radiological Protection and Nuclear Safety (IRSN). IRSN thanks ORANO for its cooperation in the elaboration of the French cohort. For the U.S. contribution, funding was provided by the National Institute for Occupational Safety and Health. Dr. Zablotska’s work was funded and supported by the CDC in association with the National Institute for Occupational Safety and Health (NIOSH) Grant (R21OH011452). For the Czech cohort, funding was provided by the National Radiation Protection Institute (SURO), grant MV-25972-2/OBV. Work on the Ontario cohort was funded by the Canadian Nuclear Safety Commission, the Ontario Ministry of Labor, and the Canadian Cancer Society. The work related to the CFCS study (Zablotska et al.) was funded by National Cancer Institute (NCI) and National Institutes of Health (NIH), Award No. R01CA197422 (Principal Investigator: LBZ). Calculation of dose conversion coefficients (DCCs) was funded by an intramural program of the Division of Cancer Epidemiology and Genetics, NCI/NIH. The studies reported by Ashley Golden were performed as part of the National Council on Radiation Protection and Measurements Million Person Study acknowledging the financial support for MPS-related science from NASA [grants # 80NSSC17M0016 and 80NSSC19M0161], U.S. DOE [grants # DE-AU0000042 and DE-AU0000046], Naval Sea Systems Command [contract # N00024-17-C-4322], CDC [grant # 5NUE1EH001315], and the U.S. NRC (grant # NRC-HQ-60-14-G-0011). All authors of this manuscript have directly participated in the planning, execution, or analysis of the study. The material is original research, has not been previously published and has not been submitted for publication elsewhere while under consideration. All authors agreed to this submission to the International Journal of Radiation Biology and agreed with the content and presentation of the manuscript. Elisa Pasqual wishes to acknowledge all the coauthors of the SEER analysis presented: Sara Schonfeld, Lindsay M Morton, Daphnee Villoing, Choonsik Lee, Amy Berrington de Gonzalez, and Cari M Kitahara.

Keywords

  • Ionizing radiation
  • epidemiology
  • lung cancer
  • medical
  • radon
  • risk

Cite this